Subcutaneous versus intravenous rituximab administration in first-line diffuse large B-cell lymphoma and follicular lymphona:Prefmab study of patient preference and satisfaction in 19 countries

Authors :: Rummel, M.
Kim, T. M.
Jensen, P.
Pereira, W. V.
Re, F.
Mendoza, M.
Osborne, S.
Smith, R.
Grigg, A.
Source :: Rummel, M, Kim, T M, Jensen, P, Pereira, W V, Re, F, Mendoza, M, Osborne, S, Smith, R & Grigg, A 2016, ' Subcutaneous versus intravenous rituximab administration in first-line diffuse large B-cell lymphoma and follicular lymphona : Prefmab study of patient preference and satisfaction in 19 countries ', Haematologica, vol. 101, no. Suppl. 1, E956, pp. 393 . < http://www.haematologica.org/content/101/s1/1.full.pdf+html >
Publication Year :: 2016

Language :: English
Database :: OpenAIRE
Journal :: Rummel, M, Kim, T M, Jensen, P, Pereira, W V, Re, F, Mendoza, M, Osborne, S, Smith, R & Grigg, A 2016, ' Subcutaneous versus intravenous rituximab administration in first-line diffuse large B-cell lymphoma and follicular lymphona : Prefmab study of patient preference and satisfaction in 19 countries ', Haematologica, vol. 101, no. Suppl. 1, E956, pp. 393 . < http://www.haematologica.org/content/101/s1/1.full.pdf+html >
Accession number :: edsair.dedup.wf.001..235fed7f72d8455bf92f03e1a46b7e3c

Tools